Unlock instant, AI-driven research and patent intelligence for your innovation.

Iridium anticancer complex containing phosphinimine dual-teeth chelating ligand and preparing method and application thereof

A technology of chelating ligands and complexes, applied in organic chemistry methods, chemical instruments and methods, organic chemistry, etc., can solve problems such as the existence of toxic and side effects

Active Publication Date: 2019-01-25
上海寻科生物医药科技有限公司
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the new generation of synthetic divalent platinum complexes has reduced some toxic side effects, the toxic side effects still exist, and the problem of drug resistance still exists

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Iridium anticancer complex containing phosphinimine dual-teeth chelating ligand and preparing method and application thereof
  • Iridium anticancer complex containing phosphinimine dual-teeth chelating ligand and preparing method and application thereof
  • Iridium anticancer complex containing phosphinimine dual-teeth chelating ligand and preparing method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] 39.8 mg iridium dimer (R 1 is methyl), 1-(2-(diphenylphosphanyl)phenyl)-N-phenylmethanimine (36.5 mg, 0.10 mmol) was placed in a 50 mL round bottom flask, and 20 mL CH 2 Cl 2 Stir at room temperature for 24 h, then 110.4 mg KPF 6 was added and continued to stir for 2 h, the solvent was spin-dried on a rotary evaporator, and an appropriate amount of CH 2 Cl 2 Dissolve the solid, filter it into a reagent bottle, slowly add 20 mL of n-hexane along the wall of the bottle to separate layers, and recrystallize by diffusion method to obtain 47 mg of a yellow solid product (yield, 54%). 1 H NMR (500 MHz, DMSO) δ 8.62 (d, J = 2.4 Hz, 1H, H C=N), 7.87 – 7.80 (m, 3H, aryl- H ), 7.72 (ddt, J = 18.3, 15.9,7.8 Hz, 11H, aryl- H ), 7.62 (t, J = 7.6 Hz, 1H, aryl- H ), 7.49 (dd, J = 10.6,7.8 Hz, 1H, aryl- H ), 7.41 (t, J = 7.5 Hz, 1H, aryl- H ), 7.12 (d, J = 7.7 Hz, 2H, aryl- H ), 1.02 (d, J = 2.3 Hz, 15H, Cp*- H ). 31 P NMR (202 MHz, DMSO) δ 11.41( P (Ph) 2...

Embodiment 2

[0056] 39.8 mg iridium dimer (R 1 is methyl), N-(2,6-dimethylphenyl)-1-(2-(diphenylphosphanyl)phenyl)methanimine (39.3 mg, 0.10 mmol) was placed in a 50 mL round bottom flask, and 20 mL CH 2 Cl 2 Stir at room temperature for 24 h, then 110.4 mg KPF 6 was added and continued to stir for 2 h, the solvent was spin-dried on a rotary evaporator, and an appropriate amount of CH 2 Cl 2 Dissolve the solid, filter it into a reagent bottle, slowly add 20 mL of n-hexane along the wall of the bottle to separate layers, and recrystallize by diffusion method to obtain 63 mg of a yellow solid product (yield, 70%). 1 H NMR (500MHz, CDCl 3 ) δ 8.07 (d, J = 3.2 Hz, 1H, H C=N), 7.72 – 7.65 (m, 4H, aryl- H ),7.64 – 7.58 (m, 5H, aryl- H ), 7.54 (td, J = 8.0, 2.8 Hz, 2H, aryl- H ), 7.28 (d,J = 3.8 Hz, 1H, aryl- H ), 7.23 (s, 1H, aryl- H ), 7.18 (d, J = 6.9 Hz, 1H, aryl- H ), 7.07 – 7.00 (m, 3H, aryl- H ), 2.27 (s, 3H, o -aniline-C H 3 ), 1.37 (s, 3H, o -aniline-C H 3 ), 1.16 (d,...

Embodiment 3

[0058] 39.8 mg iridium dimer (R 1 is methyl), N-(2,6-diisopropylphenyl)-1-(2-(diphenylphosphanyl)phenyl)methanimine (45.0 mg, 0.10 mmol) was placed in a 50 mL round bottom flask, and 20 mL CH 2 Cl 2 Stir at room temperature for 24 h, then 110.4 mg KPF 6 was added and continued to stir for 2 h, the solvent was spin-dried on a rotary evaporator, and an appropriate amount of CH 2 Cl 2 Dissolve the solid, filter it into a reagent bottle, slowly add 20 mL of n-hexane along the wall of the bottle to separate layers, and recrystallize by diffusion method to obtain 44 mg of a yellow solid product (yield, 46%). 1 H NMR (500MHz, CDCl 3 ) δ 8.07 (d, J = 2.9 Hz, 1H, H C=N), 7.68 (tt, J = 14.9, 7.4 Hz, 5H, aryl- H ), 7.63 – 7.59 (m, 1H, aryl- H ), 7.51 (dd, J = 6.7, 4.6 Hz, 4H, aryl- H ),7.34 – 7.27 (m, 3H, aryl- H ), 7.24 (d, J = 7.8 Hz, 2H, aryl- H ), 7.16 – 7.03(m, 2H, aryl- H ), 3.46 – 3.43 (m, 1H, i Pr-C H ), 2.19 – 2.12 (m, 1H, i Pr-C H ),1.38 (d, J = 6.8Hz...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an organic metal iridium anticancer complex containing phosphinimine dual-teeth chelating ligand and a preparing method thereof. The formula of the complex is shown in the description. The prepared complex has an inhibiting effect on the growth of epithelial cells (A549) of the adenocarcinoma human pulmonary alveoli base, which shows that the complex has a good in-vitro anticancer activity. The iridium complex can modify substituent groups at multiple positions, has a good anticancer activity, and is a new kind of potential anticancer drug.

Description

technical field [0001] The invention relates to a metal complex, in particular to an iridium anticancer complex containing a bidentate phosphinoimine chelate ligand, a preparation method and application thereof, and belongs to the field of chemical pharmacy. Background technique [0002] Cancer has become one of the medical problems that human beings urgently need to overcome. Chemotherapy is currently the main strategy for treating cancer. Cisplatin (PtCl), the representative of the first metal-based anticancer drug used in clinical 2 (NH 3 ) 2 , cisplatin) has limited its further clinical use due to its large toxic side effects, easy drug resistance and ineffectiveness for some tumor treatments. Therefore, searching for high-efficiency, low-toxicity, and broad-spectrum anticancer drugs has become a research hotspot in the fields of chemistry, biology, and medicine. Although the new generation of synthetic divalent platinum complexes has reduced some toxic side effects...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07F17/02A61P35/00
CPCA61P35/00C07B2200/07C07F17/02
Inventor 郭丽华刘哲杨玉亮葛兴兴
Owner 上海寻科生物医药科技有限公司